kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Promising direction for the treatment
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv Metabolic networks in mutant KRAS driven tumours: tissue specificities and the microenvironment Nature Reviews Cancer KRAS Screening and Profiling Services
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



